论文部分内容阅读
血脂康胶囊在临床上已得到广泛应用 ,但尚缺乏同系列不同剂量的调脂疗效及安全性的深入研究。本文旨在对不同剂量血脂康治疗脂质代谢异常患者的量效关系及其安全性进行探讨。1 对象和方法1.1 入选标准 1998年 4月至 2 0 0 1年 3月我院门诊及住院患者 ,根据“血脂异常防治建
Xuezhikang capsule has been widely used in clinical practice, but it still lacks the same series of different doses of lipid regulation efficacy and safety in-depth study. This article aims to explore the dose-response relationship and safety of different doses of Xuezhikang in patients with abnormal lipid metabolism. 1 objects and methods 1.1 selected criteria April 1998 to March 2001 in our hospital and hospitalized patients, according to the "prevention and treatment of dyslipidemia built